Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 114

1.

Proteolytic degradation of heme-modified hepatic cytochromes P450: A role for phosphorylation, ubiquitination, and the 26S proteasome?

Korsmeyer KK, Davoll S, Figueiredo-Pereira ME, Correia MA.

Arch Biochem Biophys. 1999 May 1;365(1):31-44.

PMID:
10222036
2.
3.

Cytochrome P450 3A degradation in isolated rat hepatocytes: 26S proteasome inhibitors as probes.

Wang HF, Figueiredo Pereira ME, Correia MA.

Arch Biochem Biophys. 1999 May 1;365(1):45-53.

PMID:
10222037
4.

Mechanism-based inactivation of cytochromes P450 2B1 and P450 2B6 by 2-phenyl-2-(1-piperidinyl)propane.

Chun J, Kent UM, Moss RM, Sayre LM, Hollenberg PF.

Drug Metab Dispos. 2000 Aug;28(8):905-11.

PMID:
10901699
5.

Aryl acetylenes as mechanism-based inhibitors of cytochrome P450-dependent monooxygenase enzymes.

Foroozesh M, Primrose G, Guo Z, Bell LC, Alworth WL, Guengerich FP.

Chem Res Toxicol. 1997 Jan;10(1):91-102.

PMID:
9074808
6.

Cytochrome P450 ubiquitination: branding for the proteolytic slaughter?

Correia MA, Sadeghi S, Mundo-Paredes E.

Annu Rev Pharmacol Toxicol. 2005;45:439-64. Review.

PMID:
15822184
7.

Hepatic cytochrome P450 degradation: mechanistic diversity of the cellular sanitation brigade.

Correia MA.

Drug Metab Rev. 2003 May-Aug;35(2-3):107-43. Review.

PMID:
12959413
9.
10.
12.
13.

Characterization of the physiological turnover of native and inactivated cytochromes P450 3A in cultured rat hepatocytes: a role for the cytosolic AAA ATPase p97?

Faouzi S, Medzihradszky KF, Hefner C, Maher JJ, Correia MA.

Biochemistry. 2007 Jul 3;46(26):7793-803. Epub 2007 Jun 6.

14.

Cytochrome P450 3A conjugation to ubiquitin in a process distinct from classical ubiquitination pathway.

Zangar RC, Kimzey AL, Okita JR, Wunschel DS, Edwards RJ, Kim H, Okita RT.

Mol Pharmacol. 2002 Apr;61(4):892-904. Erratum in: Mol Pharmacol. 2003 May;63(5):1198.

PMID:
11901229
15.

The licorice root derived isoflavan glabridin inhibits the activities of human cytochrome P450S 3A4, 2B6, and 2C9.

Kent UM, Aviram M, Rosenblat M, Hollenberg PF.

Drug Metab Dispos. 2002 Jun;30(6):709-15.

PMID:
12019199
17.

Vacuolar degradation of rat liver CYP2B1 in Saccharomyces cerevisiae: further validation of the yeast model and structural implications for the degradation of mammalian endoplasmic reticulum P450 proteins.

Liao M, Zgoda VG, Murray BP, Correia MA.

Mol Pharmacol. 2005 May;67(5):1460-9. Epub 2005 Feb 9. Erratum in: Mol Pharmacol. 2005 Jun;67(6):2186. Zgoda, Victor A [corrected to Zgoda, Victor G].

PMID:
15703377
18.

Hepatic cytochromes P450: structural degrons and barcodes, posttranslational modifications and cellular adapters in the ERAD-endgame.

Kim SM, Wang Y, Nabavi N, Liu Y, Correia MA.

Drug Metab Rev. 2016 Aug;48(3):405-33. doi: 10.1080/03602532.2016.1195403. Epub 2016 Jun 20. Review.

20.

Identification of the heme-modified peptides from cumene hydroperoxide-inactivated cytochrome P450 3A4.

He K, Bornheim LM, Falick AM, Maltby D, Yin H, Correia MA.

Biochemistry. 1998 Dec 15;37(50):17448-57.

PMID:
9860860

Supplemental Content

Support Center